Theravance Biopharma, Inc.

TBPH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001583107

SEC filings (opens in a new tab)

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Theravance Biopharma, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of TBPH: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	135	1	161	+27
Shares	46.4M	450.0K	48.4M	+2.39M (+5.2%)
Value	$512.2M	$4.96M	$706.3M	+$199.0M (+39.2%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (38)

Institutions that held Theravance Biopharma, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to TBPH in Q3 2025
Institution	Shares	Value	% of portfolio
Arrowstreet Capital, Limited Partnership	726,783	$10.6M	0.01%
Hillsdale Investment Management Inc.	310,700	$4.54M	0.14%
Algert Global LLC	199,705	$2.92M	0.05%
Janus Henderson Group PLC	127,208	$1.86M	0.00%
Man Group plc	79,791	$1.16M	0.00%
Winton Group Ltd	76,542	$1.12M	0.04%
CWM Advisors, LLC	73,556	$1.07M	0.10%
EAM Investors, LLC	66,258	$967.4K	0.11%
Baader Bank INC	53,500	$781.1K	0.06%
STRS Ohio	44,100	$643.9K	0.00%
Numerai GP LLC	28,232	$412.2K	0.06%
Quantbot Technologies LP	26,514	$387.1K	0.01%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	25,535	$372.8K	0.00%
Integrated Quantitative Investments LLC	25,172	$367.5K	0.10%
Jain Global LLC	20,204	$295.0K	0.00%
Balyasny Asset Management LLC	20,098	$293.4K	0.00%
XTX Topco Ltd	16,538	$241.5K	0.01%
Susquehanna Portfolio Strategies, LLC	14,037	$204.9K	0.00%
Longboard Asset Management, LP	13,102	$191.3K	0.31%
Quantinno Capital Management LP	12,223	$178.5K	0.00%
Sherbrooke Park Advisers LLC	12,189	$178.0K	0.08%
Petrus Trust Company, LTA	12,047	$175.9K	0.02%
PharVision Advisers, LLC	10,751	$157.0K	0.09%
Vestcor Inc	9,591	$140.0K	0.00%
SG Americas Securities, LLC	6,938	$101.0K	0.00%
Quarry LP	1,776	$25.9K	0.01%
Group One Trading, L.P.	316	$4.61K	0.00%
SRS Capital Advisors, Inc.	226	$3.30K	0.00%
Optiver Holding B.V.	194	$2.83K	0.00%
Federated Hermes, Inc.	96	$1.40K	0.00%
Smartleaf Asset Management LLC	53	$764	0.00%
Rockefeller Capital Management L.P.	51	$745	0.00%
Clearstead Advisors, LLC	20	$292	0.00%
Wealthspire Advisors, LLC	12	$175	0.00%
Sunbelt Securities, Inc.	11	$161	0.00%
SBI Securities Co., Ltd.	2	$29	0.00%
Essential Partners LLC	2	$29	0.00%
Bessemer Group Inc	1	$0	0.00%

Sold out (11)

Institutions that held Theravance Biopharma, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of TBPH in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Jefferies Financial Group Inc.	276,887	$3.05M
Capitolis Liquid Global Markets LLC	127,200	$1.40M
Y-Intercept (Hong Kong) Ltd	40,943	$451.6K
Rangeley Capital, LLC	33,729	$372.0K
Oxford Asset Management LLP	14,429	$159.2K
Point72 Asset Management, L.P.	12,692	$140.0K
Voya Investment Management LLC	11,593	$127.9K
Private Advisor Group, LLC	10,100	$111.4K
Raymond James Financial Inc	692	$7.63K
Simplex Trading, LLC	697	$7.00K
Whittier Trust Co	289	$3.19K

Not filed for Q3 2025 yet (1)

Institutions that held Theravance Biopharma, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TBPH in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Camber Capital Management LP	450,000	$4.96M